
Phase I study of rapid alternation of sunitinib and regorafenib for the treatment of tyrosine-kinase inhibitor refractory gastrointestinal stromal tumors
Serrano, César, Leal, Alessandro, Kuang, Yanan, Morgan, Jeffrey A., Barysauskas, Constance M, Phallen, Jillian, Triplett, Olivia, Mariño-Enríquez, Adrián, Wagner, Andrew J, Demetri, George D., VelculeJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-2150
Date:
August, 2019
Fichier:
PDF, 336 KB
2019